EIF5A2 and cancer: In LUAD, driver mutations in STK11 and KDM5C resided in tumor regions with predicted hypermethylation of ZNF714, MSC and EIF5A2 MethSig cancer genes with an MR/MN greater than 1 (Fig. 4e).